PRESS RELEASE: DRONEDARONE IS EFFECTIVE AND WELL-TOLERATED IN THE PREVENTION OF ATRIAL FIBRILLATION RECURRENCE

PRESS RELEASE: DRONEDARONE IS EFFECTIVE AND WELL-TOLERATED IN THE PREVENTION OF ATRIAL FIBRILLATION RECURRENCE ADONIS trial findings presented at the European Society of Cardiology meeting in Munich See attached document for more details ------------------------------------------------------------ Informasjonen er sendt gjennom Waymaker http://www.waymaker.no Nedenstående filer kan lastes ned: http://www.waymaker.net/bitonline/2004/08/30/20040830BIT20720/wkr0010.pdf Press release Sanofi - Synthelabo